TODD STRATEGY GROUP

Lobbying for AMGEN INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 21, 2025

Lobbying activity 3

Medicare/Medicaid

Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022.

Health Issues

Prescription Drug Pricing Policy. Supply Chain Issues.

Taxation/Internal Revenue Code

Prescription drug pricing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.